AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
106 hedge funds and large institutions have $33.5M invested in Accelerate Diagnostics in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 33 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
73% less capital invested
Capital invested by funds: $125M → $33.5M (-$91.1M)
94% less call options, than puts
Call options by funds: $18K | Put options by funds: $284K
Holders
106
Holding in Top 10
1
Calls
$18K
Puts
$284K
Top Buyers
| 1 | +$710K | |
| 2 | +$392K | |
| 3 | +$336K | |
| 4 |
CIA
Cladis Investment Advisory
Billings,
Montana
|
+$280K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$256K |
Top Sellers
| 1 | -$1.77M | |
| 2 | -$1.29M | |
| 3 | -$689K | |
| 4 |
Axa
Paris,
France
|
-$623K |
| 5 |
CI
Chartist Inc
Seal Beach,
California
|
-$344K |